Published by Global Banking & Finance Review®
Posted on September 17, 2025
2 min readLast updated: January 21, 2026
Add as preferred source on GoogleThe US state visit to the UK generated a record £150 billion investment, including major contributions from Blackstone and Prologis, creating 7,600 jobs.
LONDON (Reuters) -U.S. President Donald Trump's state visit to Britain has generated 150 billion pounds ($204.87 billion) of inward investment, the British government said on Wednesday citing its own data which compiled new and previously announced pledges.
The figure, which Britain said was the largest commercial investment package generated by any state visit, was announced after Trump's day of royal pageantry and ahead of the political leg of the visit, when he will meet Prime Minister Keir Starmer.
The total includes a previously reported 100 billion pound long-term investment pledge from private equity firm Blackstone, and 3.9 billion pounds from Prologis in life sciences and advanced manufacturing.
With British public opinion split over the decision to roll out the red carpet for Trump and host him for an unprecedented second state visit, the government is keen to promote its potential economic gains.
Starmer, facing intense scrutiny of his leadership after a series of political missteps, won power last July on a pledge to revive Britain's stagnant economy and improve living standards for millions of Britons. The government said the new investment would create some 7,600 new jobs.
The government also set out a series of investments flowing in the opposite direction, highlighting a $30 billion research and development investment in the United States by drugmaker GSK.
($1 = 0.7322 pounds)
(Reporting by William James; editing by Michael Holden)
The U.S. state visit generated a record 150 billion pounds ($204.87 billion) of inward investment, according to the British government.
The investment total includes a 100 billion pound long-term pledge from Blackstone and 3.9 billion pounds from Prologis in life sciences and advanced manufacturing.
The government is keen to promote the potential economic benefits of the visit amid a split public opinion on hosting President Trump.
The article also mentions a $30 billion research and development investment in the U.S. by the drugmaker GSK.
The investment figures were reported by the British government and covered by Reuters.
Explore more articles in the Headlines category
